| Announce Date | 12/19/2025 |
| EPS Normalized Actual | $0.34 (Beat by $0.0927) |
| EPS GAAP Actual | $0.34 (Beat by $0.0927) |
| Revenue Actual | $6.33B |
| Revenue Surprise | Beat by $6330M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Nov 2030 | 3.96 | 8.27 | 3.87825 | 4.05815 | 1 |
| Nov 2029 | 3.19 | 10.26 | 3.08821 | 3.36029 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.32 | 0.32 | 6.33B | 39.12% | 6330M |
| FQ3 2025 (Aug 2025) | 1.41 | 1.41 | 8.153B | 3.15% | 8153M |
| FQ2 2025 (May 2025) | 0.43 | 0.43 | 2.126B | -171.92% | 2126M |
| FQ1 2025 (Feb 2025) | -0.0596 | -0.0596 | 5.81B | 6.95% | 5810M |
| FQ4 2024 (Nov 2024) | 0.23 | 0.23 | 3.854B | -40.01% | 3854M |
| FQ3 2024 (Aug 2024) | 1.37 | 1.37 | 7.896B | 13.2% | 7896M |
| FQ2 2024 (May 2024) | 0.0726 | 0.0726 | 5.781B | 100% | 5781M |
| FQ1 2024 (Feb 2024) | -0.17 | -0.17 | 5.406B | 100% | 5406M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Aug 2028) | 1.73 | -- | 1.69175 | 1.74992 | 1 |
| FQ2 2028 (May 2028) | 0.62 | -- | 0.60629 | 0.62714 | 1 |
| FQ1 2028 (Feb 2028) | 0.28 | -- | 0.27381 | 0.28322 | 1 |
| FQ4 2027 (Nov 2027) | 0.2984 | -- | 0.29521 | 0.30149 | 1 |
| FQ3 2027 (Aug 2027) | 1.52271 | -- | 1.50642 | 1.53847 | 1 |
| FQ2 2027 (May 2027) | 0.29826 | -- | 0.29507 | 0.30135 | 1 |
| FQ1 2027 (Feb 2027) | 0.11 | -- | 0.10864 | 0.11202 | 1 |
| FQ4 2026 (Nov 2026) | 0.23877 | -34.02 | 0.23622 | 0.24124 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Aug 2028) | 9.22B | -- | 9.07B | 9.31B | 9 |
| FQ2 2028 (May 2028) | 7.18B | -- | 7.06B | 7.24B | 6 |
| FQ1 2028 (Feb 2028) | 6.58B | -- | 6.46B | 6.63B | 10 |
| FQ4 2027 (Nov 2027) | 6.46B | -- | 6.4B | 6.51B | 14 |
| FQ3 2027 (Aug 2027) | 8.58B | -- | 8.5B | 8.64B | 9 |
| FQ2 2027 (May 2027) | 6.43B | -- | 6.38B | 6.48B | 9 |
| FQ1 2027 (Feb 2027) | 6.08B | -- | 6.03B | 6.17B | 7 |
| FQ4 2026 (Nov 2026) | 6.32B | -0.2 | 6.27B | 6.37B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.32 | 0.32 | 100% | |
| FQ3 2025 (Aug 2025) | 1.41 | 1.41 | 100% | |
| FQ2 2025 (May 2025) | 0.43 | 0.43 | 100% | |
| FQ1 2025 (Feb 2025) | -0.0596 | -0.0596 | 100% | |
| FQ4 2024 (Nov 2024) | 0.23 | 0.23 | 100% | |
| FQ3 2024 (Aug 2024) | 1.37 | 1.37 | 100% | |
| FQ2 2024 (May 2024) | 0.0726 | 0.0726 | 100% | |
| FQ1 2024 (Feb 2024) | -0.17 | -0.17 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $6.33B | $6330M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $8.15B | $8153M | 100% |
| FQ2 2025 (May 2025) | $0B | $2.13B | $2126M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $5.81B | $5810M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $3.85B | $3854M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $7.9B | $7896M | 100% |
| FQ2 2024 (May 2024) | $0B | $5.78B | $5781M | 100% |
| FQ1 2024 (Feb 2024) | $0B | $5.41B | $5406M | 100% |